Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea

N-nitrosodimethylamine (NDMA), a known carcinogenic agent, was recently detected in some products of ranitidine. Several studies have investigated the detectability of NDMA, in drugs and their risks. However, only a few epidemiological studies have evaluated cancer risk from the use of such individu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Hong Jin, Kim, Jie-Hyun, Seo, Gi Hyeon, Park, Hyojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795144/
https://www.ncbi.nlm.nih.gov/pubmed/33466237
http://dx.doi.org/10.3390/jcm10010153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795144/
https://www.ncbi.nlm.nih.gov/pubmed/33466237
http://dx.doi.org/10.3390/jcm10010153

Ejemplares similares